Table 3.
Residual clinical biospecimens | Direct biospecimen procurement |
---|---|
Advantages | Advantages |
Convenience, less subject burden | More desirable/higher quality samples |
Not wasting samples—like recycling | Participants are aware of sample collection |
Cost effective and expedient for the biobank | |
Disadvantages/Concerns | Disadvantages/Concerns |
Less desirable samples | Inconvenience, subject burden |
Participants may not be aware of sample collection | Lower specimen accrual |
Unnecessary sample collection |